2022 Updates in the Treatment of Melanoma

By Memorial Sloan Kettering Cancer Center FEATURING Michael Postow

930 views

March 29, 2022

Comments 0

Overview of Skin Cancers for General Practitioners

Tarek Haykal

1.0K views

1 month ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

808 views

8 months ago

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

771 views

4 months ago

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

290 views

3 months ago

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views

8 months ago

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

712 views

4 months ago

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

AAD 2024

V. Sondak

639 views

8 months ago

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

475 views

5 months ago

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

521 views

4 months ago

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

465 views

5 months ago

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

390 views

5 months ago

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

4 months ago

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

197 views

1 month ago

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

400 views

6 months ago

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

526 views

5 months ago

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

326 views

4 months ago

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

287 views

5 months ago

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

706 views

11 months ago

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

178 views

1 month ago

Login

Login

Join VuMedi

2022 Updates in the Treatment of Melanoma

Recommended

Overview of Skin Cancers for General Practitioners

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Advances in the Treatment of Melanoma

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

ASCO® 2024 Summary: "Insights in Melanoma"

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

ESMO 2024 Summary: Metastatic Melanoma Highlights

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

Imaging Considerations for the Dermatologist

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials